Search clinical trials for: Iron Carboxymaltose

Total 1483 results

Lipomed

Completed

Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients

Hemochromatosis

Switzerland
Aga Khan University
The Hospital for Sick Children; European Union

Completed

Appropriate Complmentary Feeding Strategies in Infants (CFS)

Anemia

Pakistan
Novartis Pharmaceuticals

Completed

Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients

Iron Overload | Sickle Cell Disease | Hemolytic Anemia

United States, Canada
National Institute on Drug Abuse (NIDA)

Completed

Study Comparing Liquid and Tablet Buprenorphine Formulations - 5

Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
Baylor College of Medicine
Pharmacosmos Therapeutics, Inc.

Recruiting

IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department

Anemia, Iron Deficiency | Uterine Bleeding

United States
Neuroscience Trials Australia
The Florey Institute of Neuroscience and Mental Health

Active, not recruiting

Deferiprone to Delay Dementia (The 3D Study)

Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Mild Alzheimer's Disease

Australia
Sanofi

Terminated

Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.

Anemia

United States
Consorzio per Valutazioni Biologiche e Farmacologiche
European Commission

Completed

Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients

Chronic Iron Overload

Italy, United Kingdom, Egypt, Greece, Cyprus, Albania, Tunisia
University of Erlangen-Nürnberg Medical School
Novartis Pharmaceuticals

Terminated

Exjade-Early-Trial

Myelodysplastic Syndromes

Germany
SocraTec R&D GmbH
SocraMetrics GmbH

Completed

Characterisation of Relative Bioavailability With Bioequivalence Assessment of Deferiprone Tablets After Oral Single Dose Administration

Bioequivalence

Germany
IVI Madrid

Terminated

Aneuploidy Rate and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH

Aneuploidy Rate

Spain
Mayo Clinic

Not yet recruiting

Metal Ion Concentrations After Total Knee Arthroplasty

Arthroplasty, Replacement, Knee

United States
Shanghai 6th People's Hospital

Not yet recruiting

Efficacy and Safety of Fospropofol for Same-day Bidirectional Endoscopy in Elderly Patients

Elderly Patients
Duke University

Recruiting

Ferritin and Iron Burden in SAH sIRB

Dementia | SAH

United States
American Regent, Inc.

Completed

Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis

Anemia
University of Toronto
Canadian Institutes of Health Research (CIHR); Canadian Diabetes Association; The Physicians' Services Incorporated Foundation and other collaborators

Unknown

Meta-analyses of the Effect of 'Catalytic' Doses of Fructose and Its Epimers on Carbohydrate Metabolism

Obesity | Overweight | Metabolic Syndrome | Type 2 Diabetes | Prediabetes | Dysglycemia

Canada
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase IX - 14

Opioid-Related Disorders

United States
Novartis

Completed

Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam

Healthy
Grünenthal GmbH

Terminated

Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)

Healthy

Germany
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine. Phase V - 6

Opioid-Related Disorders

United States
DMG Dental Material Gesellschaft mbH

Withdrawn

12 Month Follow up in Vivo Icon Study on Fluorotic Teeth

Fluorosis | Oral Deseases
Cairo University

Unknown

One Year Clinical Evaluation of White Spot Lesions Treated With Newly Introduced Resin Modified Glass Ionomer in Comparison to Resin Infiltration in Anterior Teeth Split Mouth Technique

White Spot Lesions
Sun Yat-sen University

Recruiting

Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer

Triple Negative Breast Cancer

China
University of New Mexico

Recruiting

Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation

DNA Damage | Immune System Disorder

United States
Saint Luke's Health System
AstraZeneca; George Clinical Pty Ltd; Saint Luke's Hospital of Kansas City

Completed

Dapagliflozin in Respiratory Failure in Patients With COVID-19 (DARE-19)

COVID-19

United States, Brazil, Argentina, India, Canada, Mexico, United Kingdom
London School of Hygiene and Tropical Medicine

Completed

Iron Babies Pilot Supplementation Trial (Iron Babies)

Iron-deficiency | Anaemia in Early Infancy

Gambia
Abderrahmane Mami Hospital
Eshmoun Clinical Research Center; Datametrix

Unknown

Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia (TRONCHER)

COVID19 | Intensive Care Unit

Tunisia
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial

Opioid-Related Disorders | Heroin Dependence

United States
ApoPharma

Completed

Efficacy Study in Removing Excess Iron From the Heart

Hemosiderosis | Thalassemia Major

Greece, Italy
University of Zurich

Terminated

Effects of Buprenorphine on Ulnar Nerve Motor Block

Healthy Volunteers

Switzerland
Watson Pharmaceuticals

Withdrawn

Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma

Leiomyomas

United States
DMG Dental Material Gesellschaft mbH

Completed

Resin Infiltration and Resin Infiltration With Bleaching in Improving the Esthetics for Fluorosis Stains

Fluorosis | Dental Care | Caries Infiltration

India
Jian Chen

Recruiting

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

Carbon Ion Radiotherapy, Thymoma, Thymic Carcinoma, Radiotherapy, Chemotherapy

China
Ionis Pharmaceuticals, Inc.

Recruiting

A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

United States, Italy, Portugal, Spain, Taiwan, Sweden, Canada, Brazil, France, New Zealand, Argentina, Cyprus, Australia, Turkey
Ottawa Hospital Research Institute
Stryker Trauma GmbH

Completed

RCT Comparing Ion Levels and Clinical Outcomes of A-Class BFH to Metal on Polyethylene Total Hip Replacement (RCT)

Osteoarthritis | Arthroplasty | Hip Joint

Canada
Shanghai Proton and Heavy Ion Center

Withdrawn

Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Proton Radiation Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Prostate Cancer

United States
Heidelberg University
University Hospital Heidelberg

Terminated

TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors (TPF-C-HIT)

Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal Cancer

Germany
Yale University
University of British Columbia; McGill University Health Centre/Research Institute... and other collaborators

Completed

A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)

Seasonal Affective Disorder

United States, Canada, Netherlands
Sellas Life Sciences Group
Sellas Life Sciences Group

Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies

Hematologic Malignancies

United States, China
DisperSol Technologies, LLC

Completed

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Thalassemia Major

Thailand, United States
ApoPharma

Terminated

Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias (FIRST)

Iron Overload | Sickle Cell Disease | Other Anemias

United States, Turkey, United Kingdom, Egypt, Saudi Arabia, Brazil, Canada, Tunisia
Tehran University of Medical Sciences

Completed

Buprenorphine in Acute Renal Colic Pain Management

Renal Colic | Acute Pain Management

Iran, Islamic Republic of
Novartis Pharmaceuticals

Completed

Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet (Jupiter)

Non-transfusion-dependent Thalassemia | Transfusion-dependent Thalassemia

Egypt, Turkey, Thailand, Lebanon, Morocco, Saudi Arabia, Vietnam
Imperial College London

Completed

A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease (DeferipronPD)

Parkinson's Disease

United Kingdom
Vifor Pharma
Fresenius Medical Care North America

Completed

A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients

Chronic Kidney Disease Requiring Chronic Dialysis

Latvia, United States, South Africa, Belgium, Croatia, Germany, Poland, Romania, Serbia, Ukraine, United Kingdom, Austria, Czech Republic, Lithuania, Russian Federation
St. Jude Children's Research Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Stroke With Transfusions Changing to Hydroxyurea

Hematologic Diseases | Anemia, Sickle Cell | Cerebrovascular Accident | Hemochromatosis

United States

Search clinical trials for: Iron Carboxymaltose

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations